Sara Barcenilla-Garcia

Castellana, MD 28046, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors.

Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors.

Journal: Biomedicines

Published: February 12, 2026

Identifying Professional Responsibilities and Designing the Optimal Curriculum for Haemophilia Nurses in Spain: A Round Table Discussion.

Identifying Professional Responsibilities and Designing the Optimal Curriculum for Haemophilia Nurses in Spain: A Round Table Discussion.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: August 08, 2025

Real-world experience of rIX-FP prophylaxis at dosing intervals of up to 14 days in a pediatric patient with hemophilia B during the COVID-19 pandemic.

Real-world experience of rIX-FP prophylaxis at dosing intervals of up to 14 days in a pediatric patient with hemophilia B during the COVID-19 pandemic.

Journal: Clinical case reports

Published: July 12, 2023

[Translated article] Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

[Translated article] Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: October 10, 2022

The Importance of Platelet Glycoside Residues in the Haemostasis of Patients with Immune Thrombocytopaenia.

The Importance of Platelet Glycoside Residues in the Haemostasis of Patients with Immune Thrombocytopaenia.

Journal: Journal of clinical medicine

Published: February 08, 2021

Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia.

Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia.

Journal: Medicina (Kaunas, Lithuania)

Published: January 24, 2021

Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report.

Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report.

Journal: Frontiers in medicine

Published: June 26, 2020

Paradoxical effect of SARS-CoV-2 infection in patients with immune thrombocytopenia.

Paradoxical effect of SARS-CoV-2 infection in patients with immune thrombocytopenia.

Journal: British journal of haematology

Published: June 12, 2020

Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis.

Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 31, 2020

Registry of patients with congenital bleeding disorders and COVID-19 in Madrid.

Registry of patients with congenital bleeding disorders and COVID-19 in Madrid.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: May 20, 2020

COVID-19 and telemedicine in haemophilia in a patient with severe haemophilia A and orthopaedic surgery.

COVID-19 and telemedicine in haemophilia in a patient with severe haemophilia A and orthopaedic surgery.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: May 07, 2020

Clinical trials and Haemophilia during the COVID-19 pandemic: Madrid's experience.

Clinical trials and Haemophilia during the COVID-19 pandemic: Madrid's experience.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: April 23, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026